Christian Theilacker, Andrea Kropec, Felix Hammer, Irina Sava, Dominique Wobser, Tuerkan Sakinc, Jeroen D C Codée, Wouter F J Hogendorf, Gijsbert A van der Marel, Johannes Huebner
Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany. christian.theilacker@uniklinik-freiburg.de
The Journal of infectious diseases 2012 Apr 1Type 1 lipoteichoic acid (LTA) is present in many clinically important gram-positive bacteria, including enterococci, streptococci, and staphylococci, and antibodies against LTA have been shown to opsonize nonencapsulated Enterococcus faecalis strains. In the present study, we show that antibodies against E. faecalis LTA also bind to type 1 LTA from other gram-positive species and opsonized Staphylocccus epidermidis and Staphylcoccus aureus strains as well as group B streptococci. Inhibition studies using teichoic acid oligomers indicated that cross-reactive opsonic antibodies bind to the teichoic acid backbone. Passive immunization with rabbit antibodies against E. faecalis LTA promoted the clearance of bacteremia by E. faecalis and S. epidermidis in mice. Furthermore, passive protection also reduced mortality in a murine S. aureus peritonitis model. The effectiveness of rabbit antibody against LTA suggests that this conserved bacterial structure could function as a single vaccine antigen that targets multiple gram-positive pathogens.
Christian Theilacker, Andrea Kropec, Felix Hammer, Irina Sava, Dominique Wobser, Tuerkan Sakinc, Jeroen D C Codée, Wouter F J Hogendorf, Gijsbert A van der Marel, Johannes Huebner. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid. The Journal of infectious diseases. 2012 Apr 1;205(7):1076-85
PMID: 22362863
View Full Text